CYP3A in horse intestines

Toxicology and Applied Pharmacology

Volumn 201, Issue 2, 2004, Pages 112-119

  Tydén, Eva ^a   Olsén, Lena ^a   Tallkvist, Jonas ^a   Larsson, Pia ^a   Tjälve, Hans ^a  

^a Division of Pathology   (Sweden)

Author keywords

CYP3A; CYP3A activity; DFB; Horse; Immunohistochemistry; Intestine; mRNA expression

Indexed keywords

CYTOCHROME P450 3A; KETOCONAZOLE; MESSENGER RNA; VETERINARY DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CECUM; COLON; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPLASM; DRUG BIOAVAILABILITY; DRUG METABOLISM; DUODENUM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME METABOLISM; FEMALE; FIRST PASS EFFECT; GASTROINTESTINAL TRACT; HORSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE; INTESTINE CELL; JEJUNUM; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HORSES; IMMUNOHISTOCHEMISTRY; INTESTINES; MICROSOMES; MICROSOMES, LIVER; OXIDOREDUCTASES, N-DEMETHYLATING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

ANIMALIA; EQUUS CABALLUS;

EID: 8444235013     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.05.015     Document Type: Conference Paper

References (35)

1. H.L. Bonkovsky, H.P. Hauri, U. Marti, R. Gasser, and U.A. Meyer Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital Gastroenterology 88 1985 458 467
2. O. Burk, H. Tegude, I. Koch, E. Hustert, R. Wolbold, H. Glaeser, K. Klein, M.F. Fromm, A.K. Nuessler, P. Neuhaus, U.M. Zanger, M. Eichelbaum, and L. Wojnowski Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine J. Biol. Chem. 277 2002 24280 24288
3. J. Byard, D.E. Marshall, E. Houghton, and D.B. Gower Novel approaches to the purification and identification of cytochrome P450 enzymes in the equine Biochem. Soc. Trans. 24 1996 208S
4. N. Chauret, A. Gauthier, J. Martin, and D.A. Nicoll-Griffith In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse Drug Metab. Dispos. 25 1997 1130 1136
5. N. Chauret, N. Tremblay, R.L. Lackman, J.Y. Gauthier, J.M. Silva, J. Marois, J.A. Yergey, and D.A. Nicoll-Griffith Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe Anal. Biochem. 276 1999 215 226
6. M.M. Cotreau, L.L. von Moltke, M.C. Beinfeld, and D.J. Greenblatt Methodologies to study the induction of rat hepatic and intestinal cytochrome P4503A at the mRNA, protein, and catalytic activity level J. Pharmacol. Toxicol. Methods 43 2000 41 54
7. X. Ding, and L.S. Kaminsky Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts Annu. Rev. Pharmacol. Toxicol. 43 2003 149 173
8. J.R. Foster, C.R. Elcombe, A.R. Boobis, D.S. Davies, D. Sesardic, J. McQuade, R.T. Robson, C. Hayward, and E.A. Lock Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450 c Biochem. Pharmacol. 35 1986 4543 4554
9. F.J. Gonzalez The molecular biology of cytochrome P450s Pharmacol. Rev. 40 1988 243 288
10. F.P. Guengerich Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene Chem. Res. Toxicol. 3 1990 363 371
11. L.-Q. Guo, K. Fukuda, T. Ohta, and Y. Yamazoe Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity Drug Metab. Dispos. 28 2000 766 771
12. H.P. Hoensch, H.J. Steinhardt, G. Weiss, A. Maier, and H. Matchow Effects of semisynthetic diets on xenobiotic metabolizing enzyme activity and morphology of small intestinal mucosa in humans Gastroenterology 86 1984 1519 1530
13. Z. Huang, M.J. Fasco, and L.S. Kaminsky Optimization of Dnase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR BioTechniques 20 1996 1012 1020
14. I. Koch, R. Weil, R. Wolbold, J. Brockmoller, E. Hustert, O. Burk, A. Nuessler, P. Neuhaus, M. Eichelbaum, U. Zanger, and L. Wojnowski Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA Drug Metab. Dispos. 30 2002 1108 1114
15. J.C. Kolars, K.S. Lown, P. Schmiedlin-Ren, M. Ghosh, C. Fang, S.A. Wrighton, R.M. Merion, and P.B. Watkins CYP3A gene expression in human gut epithelium Pharmacogenetics 4 1994 247 259
16. M. Komori, A. Higami, Y. Imai, S. Imaoka, and Y. Funae Purification and characterization of a form of P450 from horse liver microsomes J. Biochem. (Tokyo) 114 1993 445 448
17. Y. Kyokawa, Y. Nishibe, M. Wakabayashi, T. Harauchi, T. Maruyama, T. Baba, and K. Ohno Induction of intestinal cytochrome P450 (CYP3A) by rifampicin in beagle dogs Chem.-Biol. Interact. 134 2001 291 305
18. P. Larsson, E. Persson, E. Tydén, and H. Tjälve Cell-specific activation of aflatoxin B1 correlates with presence of some cytochrome P450 enzymes in olfactory and respiratory tissues in horse Res. Vet. Sci. 74 2003 227 233
19. S.J. Lee, O.R. Hedstrom, K. Fischer, J.L. Wang-Buhler, A. Sen, I. Cok, and D.R. Buhler Immunohistochemical localization and differential expression of cytochrome P450 3A27 in the gastrointestinal tract of rainbow trout Toxicol. Appl. Pharmacol. 177 2001 94 102
20. M. Lindell, M.O. Karlsson, H. Lennernas, L. Pahlman, and M.A. Lang Variable expression of CYP and Pgp genes in the human small intestine Eur. J. Clin. Invest. 33 2003 493 499
21. K.S. Lown, D.G. Bailey, R.J. Fontana, S. Janardan, C.H. Adair, L.A. Fortlage, M.B. Brown, W. Guo, and P.B. Watkins Grapefruit juice increases oral availability in humans by decreasing intestinal CYP3A protein expression J. Clin. Invest. 99 1997 2545 2553
22. G.I. Murray, and M.D. Burke Immunohistochemistry of drug-metabolizing enzymes Biochem. Pharmacol. 50 1995 895 903
23. C. Nebbia, M. Dacasto, A. Rossetto Giaccherino, A. Giuliano Albo, and M. Carletti Comparative expression of liver cytochrome P450-dependent monooxygenases in the horse and in other agricultural and laboratory species Vet. J. 165 2003 53 64
24. M.F. Paine, M. Khalighi, J.M. Fisher, D.D. Shen, K.L. Kunze, C.L. Marsh, J.D. Perkins, and K.E. Thummel Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism J. Pharmacol. Exp. Ther. 283 1997 1552 1562
25. M.A. Pathak, F. Daniels Jr., and T.B. Fitzpatrick The presently known distribution of furocoumarins (psoralens) in plants J. Invest. Dermatol. 39 1962 225 239
26. C. Rodriguez-Antona, R. Jover, M.J. Gomez-Lechon, and J.V. Castell Quantitative RT-PCR measurement of human cytochrome P-450s: application to drug induction studies Arch. Biochem. Biophys. 376 2000 109 116
27. D.D. Shen, K.L. Kunze, and K.E. Thummel Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction Adv. Drug Delivery Rev. 27 1997 99 127
28. T. Shimada, H. Yamazaki, M. Mimura, Y. Inui, and F.P. Guengerich Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians J. Pharmacol. Exp. Ther. 270 1994 414 423
29. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk Measurement of protein using bicinchoninic acid Anal. Biochem. 150 1985 76 85
30. A. Sumida, K. Kinoshita, T. Fukuda, H. Matsuda, I. Yamamoto, T. Inaba, and J. Azuma Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver Biochem. Biophys. Res. Commun. 262 1999 499 503
31. V.J. Wacher, J.A. Silverman, Y. Zhang, and L.Z. Benet Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics J. Pharm. Sci. 87 1998 1322 1330
32. V.J. Wacher, L. Salphati, and L.Z. Benet Active secretion and enterocytic drug metabolism barriers to drug absorption Adv. Drug Delivery Rev. 46 2001 89 102
33. P.B. Watkins, S.A. Wrighton, E.G. Schuetz, D.T. Molowa, and P.S. Guzelian Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man J. Clin. Invest. 80 1987 1029 1036
34. Y. Zhang, and L.Z. Benet The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein Clin. Pharmacokinet. 40 2001 159 168
35. Q.Y. Zhang, D. Dunbar, A. Ostrowska, S. Zeisloft, J. Yang, and L.S. Kaminsky Characterization of human small intestinal cytochromes P-450 Drug Metab. Dispos. 27 1999 804 809